Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants

Summary

This will be a single-center, randomized, parallel-group, placebo-controlled study to assess the local nasal tolerability and safety of multiple administrations of topically (intranasally) administered 1146A delivered by a nasal spray applicator in healthy adult participants

Timeline

Start

2016-06-11

Primary completion

2016-07-10

Completion

2016-07-18

Drugs

Indications